OraSure Technologies Reports 4Q21 Revenue of $63.6 Million; InteliSwab® Production Scales Up
23 févr. 2022 16h05 HE
|
OraSure Technologies, Inc.
Total 2021 revenue of $233.7 million, up 36% year-over year InteliSwab® receives emergency use authorization expansion and demonstrates accurate detection of Omicron variant InteliSwab® revenue of...
OraSure Technologies, Inc. 2021 Fourth Quarter Earnings Conference Call Wednesday, February 23, 2022, 5:00 p.m. ET
16 févr. 2022 16h05 HE
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Feb. 16, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2021 fourth quarter financial results and...
InteliSwab® COVID-19 Rapid Tests Receive U.S. FDA Authorization for Pediatric Use and Company Launches New InteliSwab® Connect Reporting App
31 janv. 2022 07h05 HE
|
OraSure Technologies, Inc.
Data Demonstrates InteliSwab® is Accurate, Easy to Use, and Well Accepted by Children BETHLEHEM, Pa., Jan. 31, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader...
OraSure Technologies, Inc. Expands HIV Oral Swab In-home Test into Europe
25 janv. 2022 07h05 HE
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Jan. 25, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies,...
InteliSwab® COVID-19 Rapid Tests Detect Omicron at Same Level as Other Variants
13 janv. 2022 16h05 HE
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Jan. 13, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies,...
OraSure Technologies Announces Actions to Enhance Stockholder Value
05 janv. 2022 07h05 HE
|
OraSure Technologies, Inc.
Provides Preliminary 4Q21 Financial OutlookCommences Review of Strategic AlternativesAnnounces Transition of CEO and Organizational ChangesBETHLEHEM, Pa., Jan. 05, 2022 (GLOBE NEWSWIRE) -- OraSure...
OraSure Technologies Announces 2022 Annual Meeting Date
14 déc. 2021 07h05 HE
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Dec. 14, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) today announced that its 2022 Annual Meeting of Stockholders is scheduled to be held at 10:00 a.m. EDT...
OraSure Technologies Remains Committed to the Global Fight Against HIV 40 Years After the Discovery of the HIV Virus
30 nov. 2021 07h05 HE
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Nov. 30, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in the fight against HIV, today announced its plans for World AIDS Day. Commemorated...
OraSure Technologies to Present at Upcoming Investor Conferences
19 nov. 2021 07h05 HE
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Nov. 19, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, microbiome laboratory and...
OraSure Technologies Announces the Retirement of Jack E. Jerrett and Appointment of Agnieszka M. Gallagher as General Counsel, Chief Compliance Officer and Secretary
09 nov. 2021 07h05 HE
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Nov. 09, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies,...